Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-directed RNA polymerases I and III subunit RPAC1 (POLR1C) is a protein encoded by the POLR1C gene on chromosome 6 and is a common structural subunit of both RNA polymerase I and III complexes. These multi-subunit enzymes are responsible for the transcription of ribosomal RNA (rRNA; by polymerase I) and both tRNAs and small non-coding RNAs (by polymerase III), which are essential for ribosome assembly and protein synthesis in all living cells. POLR1C is critical for cellular and organismal viability due to its role in RNA biogenesis. Pathogenic mutations in POLR1C are linked to specific syndromic disorders, notably Treacher Collins syndrome 3 and hypomyelinating leukodystrophy, indicating its importance during early embryonic development for craniofacial and nervous system structures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA polymerases I and III subunit RPAC1 (POLR1C).